About: Phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 2007 (uk) artículu científicu espublizáu n'abril de 2007 (ast) scientific article published on 01 April 2007 (en) գիտական հոդված հրատարակված 2007 թվականի ապրիլի 1-ին (hy)
publication date	wds:Q80166987-061FBBDB-C204-46EF-ABF2-104453F63A2A
publication date	2007-04-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q80166987-E073BBFF-4D8B-4D39-8EE3-F826ECA2B106
author name string	Laura C Michaelis
rdfs:label	Phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties (en) Phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties (nl)
skos:prefLabel	Phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties (en) Phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties (nl)
name	Phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties (en) Phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties (nl)
author	wds:Q80166987-FFD09C6B-F524-4C8C-9C85-3DEEF7B14F0B
author	Mark J Ratain
title	wds:Q80166987-C897087F-813E-4438-A9E5-88ABA5A8040B
title	Phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties (en)
page(s)	wds:Q80166987-6D98B2C8-FDD6-4BF1-8228-8A75420B251A
page(s)	2400-2405
instance of	wds:Q80166987-E8B444D4-C2E6-4954-926B-8ACD732BDA44
instance of	scholarly article
main subject	wds:Q80166987-FBE80BE8-3F6C-43E4-9E10-A6D4441524EF
main subject	phase II clinical trial
PubMed ID	wds:Q80166987-41840F0D-3CCA-439F-ABE4-AB3B360FEBA2
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17438099
PubMed ID	17438099
published in	wds:Q80166987-F8097931-93B3-40F4-B774-9306F41474A2
published in	Clinical Cancer Research
issue	wds:Q80166987-657B0FA1-EAC4-4A72-8890-78691E72FD34
volume	wds:Q80166987-689B658F-C429-44E7-946B-40CB68DFA188
issue	8
volume	13
DOI	wds:Q80166987-A4F47056-E67F-4202-965D-F688F39B2186
DOI	http://dx.doi.org/10.1158/1078-0432.CCR-06-1488
DOI	10.1158/1078-0432.CCR-06-1488
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80166987
is cites work of	A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma. Resampling phase III data to assess phase II trial designs and endpoints Randomized phase II trials: a long-term investment with promising returns Analysis of the yield of phase II combination therapy trials in medical oncology Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial. Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm Recommended changes to oncology clinical trial design: revolution or evolution? Veterinary oncology clinical trials: design and implementation. Seizure and epilepsy publication in nonneurology journals
is cites work of	wds:Q34268272-EFFA756C-4B8B-427D-A37D-0B9B6ACD511C wds:Q35115259-E6E9D989-C217-4FFF-9F57-D57481297BE7 wds:Q43140987-4721F477-13B9-4774-B986-B323F16EFD03 wds:Q51549127-639E28F2-FCC8-46D9-B4FE-50993A7D447F wds:Q34193514-C899DCC0-E0D7-4736-975E-011D4854580D wds:Q38316075-1E764BDC-E152-4C26-86DD-F3DCF43BB24A wds:Q91705285-108D7E60-95D5-42D1-9DC6-7A1BDD261A40 wds:Q30620556-78CFAD8E-B192-4D5A-B8F0-B7F96C931BE4 wds:Q34144413-AAB2DAB3-9785-4C15-9499-5D6AB9BC8889

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software